[HTML][HTML] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li, J Wu… - Computational and …, 2022 - Elsevier
Abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants.
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li… - Computational and …, 2022 - europepmc.org
abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic haschallenged …
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic haschallenged …
[PDF][PDF] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li… - Computational and …, 2022 - researchgate.net
abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic haschallenged …
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic haschallenged …
[HTML][HTML] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li… - Computational and …, 2022 - ncbi.nlm.nih.gov
Abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
[引用][C] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li, J Wu… - Computational and …, 2022 - cir.nii.ac.jp
Advances in the development of therapeutic strategies against COVID-19 and perspectives in
the drug design for emerging SARS-CoV-2 variants | CiNii Research CiNii 国立情報学研究所 …
the drug design for emerging SARS-CoV-2 variants | CiNii Research CiNii 国立情報学研究所 …
[HTML][HTML] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li, J Wu… - Computational and …, 2022 - csbj.org
Abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic haschallenged …
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic haschallenged …
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang… - Computational and …, 2022 - pubmed.ncbi.nlm.nih.gov
Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified in
late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged public …
late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged public …